Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 7/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | JAK1 | P23458 | 1/20 | 0.30 |
| ▸ | TYK2 | P29597 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17409863 | 0.89 | NPC1 (0.34) | KMT2ANPC1RAB9ASMN1; SMN2KDR | |
| SCHEMBL17413599 | 0.89 | POLB (0.36) | GAAHTTKMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL17396461 | 0.87 | KMT2A (0.33) | GAAHTTKMT2ANPC1RAB9A | |
| SCHEMBL17413596 | 0.87 | GAA (0.32) | GAAHTTKMT2ARAB9APOLB | |
| SCHEMBL17413595 | 0.85 | PDK2 (0.31) | GAAHTTKMT2AJAK1 | |
| SCHEMBL19107395 | 0.82 | KMT2A (0.39) | GAAHTTKMT2ANPC1RAB9A | |
| SCHEMBL17413600 | 0.82 | GAA (0.32) | GAAHTTKMT2ANPC1RAB9A | |
| SCHEMBL17410738 | 0.81 | POLB (0.50) | GAAHTTKMT2ANPC1RAB9A | |
| SCHEMBL17413648 | 0.78 | NPC1 (0.31) | GAAHTTKMT2ANPC1RAB9A | |
| SCHEMBL17409843 | 0.78 | NPC1 (0.36) | KMT2ANPC1RAB9ASMN1; SMN2KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3160946-B1 | HERBICIDAL BENZOIC ACID AMIDES | BAYER CROPSCIENCE AG (DE) | 2018-06-06 | — | — | EP | disclosed |
| US-9988359-B2 | Herbicidally active benzoic acid amides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-06-05 | — | — | US | disclosed |
| US-20170197926-A1 | HERBICIDALLY ACTIVE BENXZOIC ACID AMIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-07-13 | — | — | US | disclosed |
| WO-2016001074-A1 | HERBICIDALLY ACTIVE BENZOIC ACID AMIDES | BAYER CROPSCIENCE AG (DE) | 2016-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170197926-A1 | HERBICIDALLY ACTIVE BENXZOIC ACID AMIDES | AOX1, GABRA5, GABRD | GAA 192/4885HTT 1030/4885KMT2A 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.